In the Key Note 2 presentation from the Cardiomyopathy UK National Conference 2023, Perry Elliott, Professor in Inherited Cardiovascular Disease at University College London, asks ‘What does the future hold for people affected by cardiomyopathy?’.
Chapters:
00:02:19 - Cardiomyopathies: The beginning
00:03:06 - 2023 ESC Cardiomyopathy Guidelines
00:04:46 - The current treatment paradigm
00:05:30 - So, what’s next?
00:06:20 - Gene variant and risk of sudden cardiac death in dilated cardiomyopathy
00:08:25 - Gene variant and risk of lifetime burden of disease in hypertrophic cardiomyopathy
00:09:44 - Living with cardiomyopathy
00:11:39 - Case study - Cardiac Amyloidosis
00:15:20 - Left Ventricular Outflow Tract Obstruction (LVOTO)
00:21:17 - Heart failure
00:22:53 - Nucleic Acid Therapies (gene therapy)
00:26:36 - Genome editing (CRISPR)
Find out more at www.cardiomyopathy.org
#cardiomyopathy #heartmuscledisease #pacemaker #ICD #CRT #S-ICD #defibrillator #ILR #cardiomyopathyawareness #cardiacrehab #cardiacrehabilitation #CardioConference #mavacamten #MRI #Echo #CMRi #ACM #HCM #DCM #ESC #PPCM #Takotsubo
Негізгі бет New Horizons in Cardiomyopathy; What Does the Future Hold? Prof Perry Elliott
Пікірлер: 1